StonvexLoading…
StonvexStonvexStonvexCore line items from ACT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.24B | $1.20B | $1.15B | $1.10B |
Operating Income | $858.84M | $878.06M | $851.51M | $898.22M |
Net Income | $674.24M | $688.07M | $665.51M | $704.16M |
EPS (Diluted) | $4.52 | $4.37 | $4.11 | $4.31 |
Total Assets | $6.89B | $6.52B | $6.19B | $5.71B |
Total Liabilities | $1.54B | $1.53B | $1.56B | $1.61B |
Cash & Equivalents | $582.49M | $599.43M | $615.68M | $513.77M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 142.21M | 152.32M | 159.34M | 162.78M |